Kevin Rooney
Director/Board Member at National Foundation for Infectious Diseases
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Patricia A. Stinchfield | F | - |
National Foundation for Infectious Diseases
 National Foundation for Infectious Diseases Miscellaneous Commercial ServicesCommercial Services National Foundation for Infectious Diseases engages in providing information and resources about vaccines recommended for adults, adolescents and children, including links to updated Center for Disease Control and Prevention (CDC) Immunization Schedules and a Fact Sheet about how vaccines work. The company is headquartered in Bethesda, MD. | - |
| Keipp B. Talbot | M | - |
National Foundation for Infectious Diseases
National Foundation for Infectious Diseases Miscellaneous Commercial ServicesCommercial Services National Foundation for Infectious Diseases engages in providing information and resources about vaccines recommended for adults, adolescents and children, including links to updated Center for Disease Control and Prevention (CDC) Immunization Schedules and a Fact Sheet about how vaccines work. The company is headquartered in Bethesda, MD. | - |
| Jonathan Peskoff | M | 51 |
F3 Platform Biologics, Inc.
 F3 Platform Biologics, Inc. BiotechnologyHealth Technology F3 Platform Biologics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and practical biotechnology for human use. It handles research, clinical development, and commercialization of new indications surrounding amifostine, a compound that has been previously approved by FDA for indications involving the prevention and treatment of side effects related to cancer treatment and radiation therapy. The company was founded on June 5, 2018 and is headquartered in Atlanta, GA. | 6 years |
| James Miller | M | 58 |
F3 Platform Biologics, Inc.
F3 Platform Biologics, Inc. BiotechnologyHealth Technology F3 Platform Biologics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and practical biotechnology for human use. It handles research, clinical development, and commercialization of new indications surrounding amifostine, a compound that has been previously approved by FDA for indications involving the prevention and treatment of side effects related to cancer treatment and radiation therapy. The company was founded on June 5, 2018 and is headquartered in Atlanta, GA. | 6 years |
| Robert Hopkins | M | - |
National Foundation for Infectious Diseases
National Foundation for Infectious Diseases Miscellaneous Commercial ServicesCommercial Services National Foundation for Infectious Diseases engages in providing information and resources about vaccines recommended for adults, adolescents and children, including links to updated Center for Disease Control and Prevention (CDC) Immunization Schedules and a Fact Sheet about how vaccines work. The company is headquartered in Bethesda, MD. | 1 years |
| Joseph A. Bocchini | M | - |
National Foundation for Infectious Diseases
National Foundation for Infectious Diseases Miscellaneous Commercial ServicesCommercial Services National Foundation for Infectious Diseases engages in providing information and resources about vaccines recommended for adults, adolescents and children, including links to updated Center for Disease Control and Prevention (CDC) Immunization Schedules and a Fact Sheet about how vaccines work. The company is headquartered in Bethesda, MD. | - |
| Walter A. Orenstein | M | - |
National Foundation for Infectious Diseases
National Foundation for Infectious Diseases Miscellaneous Commercial ServicesCommercial Services National Foundation for Infectious Diseases engages in providing information and resources about vaccines recommended for adults, adolescents and children, including links to updated Center for Disease Control and Prevention (CDC) Immunization Schedules and a Fact Sheet about how vaccines work. The company is headquartered in Bethesda, MD. | - |
| Kimberly McCutcheon Jablonski | F | - | 21 years | |
| Marla Dalton | F | - |
National Foundation for Infectious Diseases
National Foundation for Infectious Diseases Miscellaneous Commercial ServicesCommercial Services National Foundation for Infectious Diseases engages in providing information and resources about vaccines recommended for adults, adolescents and children, including links to updated Center for Disease Control and Prevention (CDC) Immunization Schedules and a Fact Sheet about how vaccines work. The company is headquartered in Bethesda, MD. | - |
| Holger Liepmann | M | 72 |
F3 Platform Biologics, Inc.
F3 Platform Biologics, Inc. BiotechnologyHealth Technology F3 Platform Biologics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and practical biotechnology for human use. It handles research, clinical development, and commercialization of new indications surrounding amifostine, a compound that has been previously approved by FDA for indications involving the prevention and treatment of side effects related to cancer treatment and radiation therapy. The company was founded on June 5, 2018 and is headquartered in Atlanta, GA. | - |
| Cynthia Pellegrini | F | - |
National Foundation for Infectious Diseases
National Foundation for Infectious Diseases Miscellaneous Commercial ServicesCommercial Services National Foundation for Infectious Diseases engages in providing information and resources about vaccines recommended for adults, adolescents and children, including links to updated Center for Disease Control and Prevention (CDC) Immunization Schedules and a Fact Sheet about how vaccines work. The company is headquartered in Bethesda, MD. | - |
| Ruth Lynfield | M | - |
National Foundation for Infectious Diseases
National Foundation for Infectious Diseases Miscellaneous Commercial ServicesCommercial Services National Foundation for Infectious Diseases engages in providing information and resources about vaccines recommended for adults, adolescents and children, including links to updated Center for Disease Control and Prevention (CDC) Immunization Schedules and a Fact Sheet about how vaccines work. The company is headquartered in Bethesda, MD. | - |
| Sara E. Cosgrove | M | - |
National Foundation for Infectious Diseases
National Foundation for Infectious Diseases Miscellaneous Commercial ServicesCommercial Services National Foundation for Infectious Diseases engages in providing information and resources about vaccines recommended for adults, adolescents and children, including links to updated Center for Disease Control and Prevention (CDC) Immunization Schedules and a Fact Sheet about how vaccines work. The company is headquartered in Bethesda, MD. | - |
| Richard J. Duma | M | - |
National Foundation for Infectious Diseases
National Foundation for Infectious Diseases Miscellaneous Commercial ServicesCommercial Services National Foundation for Infectious Diseases engages in providing information and resources about vaccines recommended for adults, adolescents and children, including links to updated Center for Disease Control and Prevention (CDC) Immunization Schedules and a Fact Sheet about how vaccines work. The company is headquartered in Bethesda, MD. | - |
| Kathleen M. Neuzil | M | - |
National Foundation for Infectious Diseases
National Foundation for Infectious Diseases Miscellaneous Commercial ServicesCommercial Services National Foundation for Infectious Diseases engages in providing information and resources about vaccines recommended for adults, adolescents and children, including links to updated Center for Disease Control and Prevention (CDC) Immunization Schedules and a Fact Sheet about how vaccines work. The company is headquartered in Bethesda, MD. | - |
| Lisa S. Ipp | M | - |
National Foundation for Infectious Diseases
National Foundation for Infectious Diseases Miscellaneous Commercial ServicesCommercial Services National Foundation for Infectious Diseases engages in providing information and resources about vaccines recommended for adults, adolescents and children, including links to updated Center for Disease Control and Prevention (CDC) Immunization Schedules and a Fact Sheet about how vaccines work. The company is headquartered in Bethesda, MD. | - |
| Jeffrey A. Goad | M | - |
National Foundation for Infectious Diseases
National Foundation for Infectious Diseases Miscellaneous Commercial ServicesCommercial Services National Foundation for Infectious Diseases engages in providing information and resources about vaccines recommended for adults, adolescents and children, including links to updated Center for Disease Control and Prevention (CDC) Immunization Schedules and a Fact Sheet about how vaccines work. The company is headquartered in Bethesda, MD. | - |
| Bernardus MacHielse | M | 63 |
F3 Platform Biologics, Inc.
F3 Platform Biologics, Inc. BiotechnologyHealth Technology F3 Platform Biologics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and practical biotechnology for human use. It handles research, clinical development, and commercialization of new indications surrounding amifostine, a compound that has been previously approved by FDA for indications involving the prevention and treatment of side effects related to cancer treatment and radiation therapy. The company was founded on June 5, 2018 and is headquartered in Atlanta, GA. | - |
| Cristina Cassetti | M | - |
National Foundation for Infectious Diseases
National Foundation for Infectious Diseases Miscellaneous Commercial ServicesCommercial Services National Foundation for Infectious Diseases engages in providing information and resources about vaccines recommended for adults, adolescents and children, including links to updated Center for Disease Control and Prevention (CDC) Immunization Schedules and a Fact Sheet about how vaccines work. The company is headquartered in Bethesda, MD. | - |
| Ruth M. Carrico | M | - |
National Foundation for Infectious Diseases
National Foundation for Infectious Diseases Miscellaneous Commercial ServicesCommercial Services National Foundation for Infectious Diseases engages in providing information and resources about vaccines recommended for adults, adolescents and children, including links to updated Center for Disease Control and Prevention (CDC) Immunization Schedules and a Fact Sheet about how vaccines work. The company is headquartered in Bethesda, MD. | - |
| Beth P. Bell | M | - |
National Foundation for Infectious Diseases
National Foundation for Infectious Diseases Miscellaneous Commercial ServicesCommercial Services National Foundation for Infectious Diseases engages in providing information and resources about vaccines recommended for adults, adolescents and children, including links to updated Center for Disease Control and Prevention (CDC) Immunization Schedules and a Fact Sheet about how vaccines work. The company is headquartered in Bethesda, MD. | - |
| Daniel Courchesne | M | - |
F3 Platform Biologics, Inc.
F3 Platform Biologics, Inc. BiotechnologyHealth Technology F3 Platform Biologics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and practical biotechnology for human use. It handles research, clinical development, and commercialization of new indications surrounding amifostine, a compound that has been previously approved by FDA for indications involving the prevention and treatment of side effects related to cancer treatment and radiation therapy. The company was founded on June 5, 2018 and is headquartered in Atlanta, GA. | 5 years |
| Linda Peters | F | - |
F3 Platform Biologics, Inc.
F3 Platform Biologics, Inc. BiotechnologyHealth Technology F3 Platform Biologics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and practical biotechnology for human use. It handles research, clinical development, and commercialization of new indications surrounding amifostine, a compound that has been previously approved by FDA for indications involving the prevention and treatment of side effects related to cancer treatment and radiation therapy. The company was founded on June 5, 2018 and is headquartered in Atlanta, GA. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Giovanni Caforio | M | 59 | 24 years | |
| Lamberto Andreotti | M | 73 | 19 years | |
| Charles A. Heimbold | M | - | 20 years | |
| Bahija Jallal | M | 62 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | 13 years |
| Paul H. Fischer | M | 74 | 17 years | |
| Cynthia Collins | F | 65 | 1 years | |
| John E. Elicker | M | 64 | 20 years | |
| Lewis B. Campbell | M | 77 | 18 years | |
| Leif Valdemar Johansson | M | 73 | 13 years | |
| Joseph Squicciarino | M | 67 | 22 years | |
| Barry J. Wolfenson | M | 57 | 23 years | |
| Rosemary Crane | F | 64 | 20 years | |
| Mark E. Spring | M | - |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | 3 years |
| Jason Haddock | M | 54 | 14 years | |
| Timothy Meeker | M | 77 | 13 years | |
| Edward M. Connor | M | 72 | 2 years | |
| Brian Daniels | M | 65 | 14 years | |
| Gerald Bruce | M | 68 | 8 years | |
| Adel Mahmoud | M | 82 | 2 years | |
| Fouad Namouni | M | 55 | 21 years | |
| Michael Tardugno | M | 73 | 2 years | |
| Robert Peach | M | 68 | 9 years | |
| Kenneth E. Lebioda | M | - | 5 years | |
| Stéphane Thiroloix | M | - | - | |
| Robert Roche | M | 57 | 6 years | |
| Jane A. Kramer | F | 68 | 11 years | |
| Peter Nicklin | M | 61 | 14 years | |
| Michael J. Howerton | M | 72 | - | |
| Samuel Barker | M | 81 | - | |
| Beth Anne Piper | M | - | 4 years | |
| Enrique Sendagorta Gomendio | M | - | - | |
| James E. Foley | M | - | - | |
| Patricia Bellinger | F | 63 | 5 years | |
| Fu-Min Su | M | - | 6 years | |
| James Patrick McDermott | M | - | 3 years | |
| Douglas C. Plessinger | M | 55 | 6 years | |
| Thomas J. McKearn | M | 75 | 10 years | |
| Ning Yan | M | - | 7 years | |
| Dieter Weinand | M | 63 | 9 years | |
| John H. Lawrence | M | - | 18 years | |
| Kelly Slieter | F | 49 | 1 years | |
| Yadagiri R Pendri | M | 68 | 7 years | |
| Benjamin Winograd | M | 63 | 9 years | |
| Gary Dickinson | M | 72 | 4 years | |
| Andrew Bonfield | M | 61 | 5 years | |
| Peter Kiener | M | 72 | 18 years | |
| Lynn H. Clark | F | 66 | 8 years | |
| Steven E. Benner | M | 64 | 7 years | |
| Stephen E. Bear | M | 73 | 7 years | |
| Dean Mitchell | M | 68 | 3 years | |
| Steven R. Arikian | M | 65 | 2 years | |
| James G. Ham | M | 74 | 7 years | |
| David L. Zabor | M | 69 | - | |
| Robert Francis Doman | M | 74 | 8 years | |
| Barry A. Labinger | M | 60 | 3 years | |
| Bruce Wendel | M | 70 | 14 years | |
| Timothy McNamara | M | 67 | 9 years | |
| Michael A. Popson | M | - | 6 years | |
| Andrew Shenker | M | 69 | 5 years | |
| Freda Lewis-Hall | M | 69 | 5 years | |
| Susan Mahony | M | 59 | 5 years | |
| David Apelian | M | 59 | 2 years | |
| Phillip John Brancazio | M | 71 | 23 years | |
| Francis Cuss | M | 70 | 14 years | |
| Helen Torley | M | 61 | 5 years | |
| Stuart Tross | M | 57 | 8 years | |
| Christine Poon | F | 71 | 3 years | |
| Stephen Sadove | M | 72 | 10 years | |
| John D. Macomber | M | 96 | 5 years | |
| Louis T. DiFazio | M | 86 | 7 years | |
| Daniel Lynch | M | 65 | 15 years | |
| Robert L. Simon | M | 79 | 13 years | |
| Timothy P. Cost | M | 65 | 5 years | |
| Andrew Bodnar | M | 75 | - | |
| Matthew Wikler | M | 74 | 4 years | |
| Rick Winningham | M | 64 | 4 years | |
| Laura Bessen | M | 61 | 15 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Kevin Rooney
- Personal Network
